Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$57.18 -1.26 (-2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Interest & Investment Income (2009 - 2026)

Updated

Biomarin Pharmaceutical's Interest & Investment Income was $10.48 million in Q2 2026, down 44.3% from $18.83 million a year earlier and down 53.5% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Interest & Investment Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Biomarin Pharmaceutical's Interest & Investment Income was $70.1 million through Jun 30, 2026, down 4.7% year-over-year; for FY2025, it was $74.9 million, unchanged from FY2024.

  • Interest & Investment Income shows a five-year compound annual growth rate of 35.2% (FY2020 to FY2025).
  • In earlier years, Interest & Investment Income was $74.88 million in FY2024 (+28.4%), $58.34 million in FY2023 (+223.5%), $18.03 million in FY2022 (+72.0%) and $10.48 million in FY2021 (-36.9%).
  • The Q2 2026 figure marks the lowest quarterly Interest & Investment Income since Q4 2022.
  • Compared with a year earlier, Interest & Investment Income was higher in three of the last eight quarters, with an average decline of 1.5%.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q1 2023 (growth of 556.2%); the worst was Q3 2021 (a decline of 54.4%).
  • Per Business Quant data, BMRN's Interest & Investment Income in the three quarters before Q2 2026 was $22.56 million (Q1 2026), $19.21 million (Q4 2025) and $17.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Biomarin Pharmaceutical 11.07 Bn 4.93 Bn 786.91 Mn 10.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.48 Mn
Mar 31, 2026 22.56 Mn
Dec 31, 2025 19.21 Mn
Sep 30, 2025 17.85 Mn
Jun 30, 2025 18.83 Mn
Mar 31, 2025 19.01 Mn
Dec 31, 2024 17.68 Mn
Sep 30, 2024 18.05 Mn
Jun 30, 2024 19.79 Mn
Mar 31, 2024 19.37 Mn
Dec 31, 2023 18.04 Mn
Sep 30, 2023 15.74 Mn
Jun 30, 2023 12.61 Mn
Mar 31, 2023 11.94 Mn
Dec 31, 2022 8.71 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 2.51 Mn
Mar 31, 2022 1.82 Mn
Dec 31, 2021 1.75 Mn
Sep 30, 2021 1.83 Mn
API Access

Biomarin Pharmaceutical Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BMRN&period=max&api_key=YOUR_API_KEY